Gene therapy for hemophilia represents a groundbreaking advancement in hemophilia treatment, holding the potential to transform the lives of those affected by this genetic disorder.With the recent FDA approval of Hemgenix, a novel gene therapy, patients like Terence Blue are experiencing remarkable improvements in their condition, reducing reliance on traditional clotting factor treatments.